Nashville journey undertaken by a woman from Chattanooga for pioneering cancer surgery
In the heart of Nashville, Ascension Saint Thomas Hospital is making waves in the medical community with its adoption of the groundbreaking advancement, Cytalux. This FDA-approved imaging agent is revolutionising surgical treatment for ovarian and lung cancer patients, offering increased precision and improved outcomes.
Dr. John Lazar, a seasoned thoracic surgeon at Ascension Saint Thomas, has been practicing for about a decade and has been part of the hospital's team for the past two years. Dr. Lazar was one of the early adopters of Cytalux, and he firmly believes it to be a "game changer."
Recently, Dr. Lazar had the opportunity to help Katherine Jacobson, a patient from Chattanooga, Tennessee, who was diagnosed with lung cancer in October 2024. Thanks to Cytalux, Jacobson was referred to Dr. Lazar in Nashville. The technology played a crucial role in helping Dr. Lazar locate Jacobson's tumor, which she believes would have been challenging without the aid of Cytalux.
Jacobson, who initially found it difficult to cope with her diagnosis and the wait for treatment, expressed her gratitude for Dr. Lazar's expertise and the life-saving technology. Today, she continues her communication with Dr. Lazar and is happily travelling with her husband.
The success story of Katherine Jacobson is not unique. Ascension Saint Thomas, being the only hospital in Tennessee using Cytalux during surgeries, has expanded Dr. Lazar's practice to reach more patients like Jacobson. This cutting-edge technology has enabled Dr. Lazar to more precisely identify and remove cancerous tissue, potentially leading to better patient outcomes.
Dr. Lazar encourages other doctors to consider using Cytalux as a surgical tool. He believes that Cytalux is the "next wave" in surgical treatment, offering a brighter future for cancer patients.
As Jacobson prepares for her follow-up scans to monitor her progress, she carries with her the hope that this groundbreaking technology will continue to save lives and provide a beacon of hope for those battling cancer.
On World Lung Cancer Day, observed on August 1, let us celebrate the advancements in medical technology that are making a difference in the lives of patients like Katherine Jacobson.
[1] Ascension Saint Thomas Adopts Cutting-Edge Cytalux Technology for Lung Cancer Surgery [2] Dr. John Lazar: Cytalux is a "Game Changer" for Thoracic Surgery [3] Tennessee's Ascension Saint Thomas Leads in Lung Cancer Surgery with Cytalux Adoption [4] Katherine Jacobson's Journey: From Lung Cancer Diagnosis to Hope with Cytalux [5] Cytalux: Improving Tumor Detection and Resection in Lung Cancer Surgery
[1] The adoption of the cutting-edge Cytalux technology at Ascension Saint Thomas Hospital is revolutionizing the surgical treatment of medical-conditions like ovarian and lung cancer, offering enhanced precision and improved outcomes for health-and-wellness.
[2] Dr. John Lazar, a prominent thoracic surgeon at Ascension Saint Thomas, has been a proponent of Cytalux, deeming it a "game changer" in health-and-wellness technology for cancer patients, as evidenced by the successful surgeries and outcomes of patients like Katherine Jacobson.
